FREE Case Review (866) 588-0600

Taxotere MDL Surpasses 1100 Hair Loss Lawsuits

The federal Taxotere MDL has grown to include more than 1,100 permanent hair loss lawsuits.

The federal multidistrict litigation (MDL No. 2740) for lawsuits alleging permanent hair loss or “alopecia” from the chemotherapy drug Taxotere (generic: docetaxel) has grown from just a handful of cases a year ago to more than 1,100 complaints.

Free Confidential Lawsuit Evaluation: If you or a loved one suffered permanent hair loss, alopecia or baldness after chemotherapy with Taxotere, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the problem?

June 6, 2017 – The litigation, In Re: Taxotere (Docetaxel) Products Liability Litigation, MDL No. 2740, US District Court, Eastern District of Louisiana, concerns the allegations of hundreds of cancer patients who claim they lost hair that never grew back following chemo with docetaxel.

While temporary hair loss is a common side effect of cancer treatment drugs, this complication is often permanent and irreversible with Taxotere, according to the lawsuits.

Approved by the U.S. Food & Drug Administration (FDA) in 1996, Taxotere is administered intravenously and used to treat breast cancer, non-small lung cancer and prostate cancer. The medicine’s labeling warns of several potential side effects including low blood cell count, allergic reactions, fluid retention, gastrointestinal problems and hair loss.

The Taxotere prescribing information currently states that “In most cases normal hair growth should return,” but also that “In some cases (frequency not known) permanent hair loss has been observed.”

There are now at least 1,116 Taxotere lawsuits pending in the Eastern District of Louisiana, according to a joint report submitted May 12. The report also indicated that at least 3 defendants have been dismissed from liability in the lawsuits.

One of the companies, Apotex Inc., submitted proof that it had never manufactured docetaxel. The others, Northstar RX LLC and Eagle Pharmaceuticals, proved that they didn’t make docetaxel until after the injuries alleged by individual complainants.

The next status conference in the Taxotere litigation is set for July 7, 2017.

Do I Have a Taxotere Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Taxotere lawsuits. We are handling individual litigation nationwide and currently accepting new hair loss and alopecia cases in all 50 states.

Free Case Evaluation: Again, if you lost hair and failed to regrow it following chemo with Taxotere, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition